Karyopharm Therapeutics Inc. buy me8
Start price
05.02.24
/
0%
€1.35
Target price
05.02.25
-
Performance (%)
29.34%
End price
06.02.24
€1.75
Summary
This prediction ended on 06.02.24 with a price of €1.75. The prediction had a final performance of 29.34%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | -6.615% | -6.615% |
| iShares Core DAX® | 3.178% | 0.980% |
| iShares Nasdaq 100 | 2.972% | 0.925% |
| iShares Nikkei 225® | 0.545% | -4.556% |
| iShares S&P 500 | 2.367% | 0.833% |
According to me8 what are the pros and cons of Karyopharm Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Cons
Few uniques
Comments by me8 for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Buy Karyopharm Therapeutics Inc.